StockData
argenx SE logo

argenx SE (ARGX) stock

ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 5/30
$941.25−6.27 (-0.66%)

Close on Nov 18, 2026Market cap –P/E 48.1Yield –

argenx pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

argenx's pe ratio was 50.0× on Nov 11, 2026, against 71.4× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202650.0×−15.8
2025Dec 31, 202565.8×–

More argenx figures

See a number that looks wrong?